ENCRX
Live / Allowed — Third extension granted (statement of use) (as of 24 Jun 2026)
What this means for you
Approved and waiting on proof of use. It will register unless the applicant drops it, and its 19 Jan 2024 filing date already counts against anyone who files later.
Record
- Serial number
- 98366145
- Mark type
- Word mark
- Filed
- 19 Jan 2024
- Published for opposition
- 26 Nov 2024
- Attorney of record
- Winfield B. Martin
Goods and services
- Class 005 — Pharmaceuticals: Pharmaceutical products for treatment of chronic diseases by means of gene and cell therapy, encapsulated cell therapy, and implantable cell therapy; living cells for implantable cell therapy; living cells for gene and cell therapy, encapsulated cell therapy, and implantable cell therapy; living cells for medical use, namely, encapsulated cells delivered by implantable cell therapy devices for secreting drugs and/or molecules; encapsulated pharmaceutical products for the treatment of chronic diseases; implantable pharmaceutical products for the treatment of chronic diseases; encapsulated pharmaceutical product for the treatment of chronic diseases delivered by implantable encapsulation devices with encapsulated cells for secreting drugs
- Class 010 — Medical apparatus: Cell encapsulation devices in the nature of implantable drug and/or molecule and cell therapy delivery ports; implantable cell encapsulation devices in the nature of implantable drug and/or molecule and cell therapy delivery ports; implantable cell therapy devices in the nature of implantable drug and/or molecule and cell therapy delivery ports; drug and prescription encapsulation devices in the nature of implantable drug and cell therapy delivery ports; implantable drug and prescription encapsulation devices in the nature of implantable drug and cell therapy delivery ports; implantable drug and prescription delivery devices in the nature of implantable drug and cell therapy delivery ports
Owner
- Encellin, Inc., Palo Alto, CA, US
- Encellin, Inc., Palo Alto, CA, US
Prosecution history
- 25 Jun 2026 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 24 Jun 2026 — SOU EXTENSION 3 GRANTED
- 24 Jun 2026 — SOU EXTENSION 3 FILED
- 24 Jun 2026 — SOU TEAS EXTENSION RECEIVED
- 08 Jan 2026 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 07 Jan 2026 — SOU EXTENSION 2 GRANTED
- 07 Jan 2026 — SOU EXTENSION 2 FILED
- 07 Jan 2026 — SOU TEAS EXTENSION RECEIVED
- 03 Jul 2025 — TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS
- 03 Jul 2025 — TEAS CHANGE OF CORRESPONDENCE RECEIVED
- 03 Jul 2025 — ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
- 03 Jul 2025 — TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
- 04 Jul 2025 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 03 Jul 2025 — SOU EXTENSION 1 GRANTED
- 03 Jul 2025 — SOU EXTENSION 1 FILED